logo
Send Message
Hefei Home Sunshine Pharmaceutical Technology Co.,Ltd
products
products
Home > products > Pharmaceutical Intermediates > AHU-377 (heMicalciuM Salt) CAS 1369773-39-6

AHU-377 (heMicalciuM Salt) CAS 1369773-39-6

Product Details

Place of Origin: China

Brand Name: Sunshine

Certification: ISO,COA

Model Number: 1369773-39-6

Payment & Shipping Terms

Minimum Order Quantity: Negotiation

Price: Negotiation

Packaging Details: Aluminum Foil Bag, Drum

Delivery Time: 7-15DAY

Payment Terms: L/C,D/A,T/T,D/P,Western Union,MoneyGram

Supply Ability: G,KG,TON

Get Best Price
Highlight:
CAS NO::
1369773-39-6
Appearance::
White To Beige Powder
Molecular Formula::
C48H56CaN2O10
Molecular Weight::
861.04400
EINECS NO::
935-847-3
MDL NO::
MFCD28137893
CAS NO::
1369773-39-6
Appearance::
White To Beige Powder
Molecular Formula::
C48H56CaN2O10
Molecular Weight::
861.04400
EINECS NO::
935-847-3
MDL NO::
MFCD28137893
AHU-377 (heMicalciuM Salt) CAS 1369773-39-6

Product Description:

Product Name: AHU-377 (heMicalciuM salt) CAS NO: 1369773-39-6


Synonyms:

[1,1'-Biphenyl]-4-pentanoic acid, γ-[(3-carboxy-1-oxopropyl)amino]-α-methyl-, 4-ethyl ester, calcium salt (2:1), (αR,γS)-;

(alphaR,gammaS)-gamma-[(3-Carboxy-1-oxopropyl)amino]-alpha-methyl-[1,1'-biphenyl]-4-pentanoic acid 4-ethyl ester calcium salt (2:1);

Calcium 4-(((2S,4R)-1-([1,1'-biphenyl]-4-yl)-5-ethoxy-4-methyl-5-oxopentan-2-yl)amino)-4-oxobutanoate;


Chemical & Physical Properties:

Appearance: White to beige powder

Assay :≥99.00%

Storage temp.: -20℃


Safety Information:

RIDADR: UN2811 - class 6.1 - PG 3 - EHS - Toxic solids, organic, n.o.s., HI: all

Symbol: GHS06, GHS09

Signal Word: Danger

Hazard Statements: H301-H400

Precautionary Statements: Missing Phrase - N15.00950417


Sacubitril (AHU-377) hemicalcium salt is a potent NEP inhibitor with an IC50 of 5 nM. Sacubitril hemicalcium salt is a component of the heart failure medicine LCZ696.


If you are interested in our products or have any questions, please feel free to contact us!


Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.